Bruker Hits a 52-Week High Following Acquisition News | GenomeWeb
Bruker BioSciences’ stock reached a new 52-week high of $12.24 this week after the firm announced that it would acquire affiliated company Bruker BioSpin for $914 million (see related article, this issue). Bruker’s shares rose 38.2 percent for the five-day trading week ended Tuesday to lead all gainers in the BCW Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.